New horizons in migraine therapy CGRP monoclonal antibodies

Research output: Contribution to journalArticleOtherpeer-review

1 Citation (Scopus)

Abstract

Migraine is one of the most common and disabling diseases worldwide. However, few disease-specific treatments exist. Calcitonin-gene related peptide (CGRP) monoclonal antibodies are a new class of medication for migraine that represent a welcome addition to our armamentarium for migraine.

Original languageEnglish
Pages (from-to)61-64
Number of pages4
JournalMedicine Today
Volume22
Issue number6
Publication statusPublished - Jun 2021

Cite this